Neurocrine’s $2.9 Billion Bet: A Strategic Move Into Rare Diseases In a major move that could reshape its future, Neurocrine Biosciences has…
From Price Hikes to Supply Shifts: The Real Impact of Trump’s Tariffs
4 Mins read
One Year Later: How Trump’s Tariffs Changed Business in America It’s been a year since Donald Trump introduced sweeping tariffs on imports…
Patent Expiries Trigger Deal Frenzy as Drugmakers Turn to Biotech M&A
4 Mins read
Global pharmaceutical giants are accelerating efforts to acquire biotech companies and late-stage drug assets as the industry braces for a looming “patent…
The Shocking Rise of Eli Lilly: How One Weight-Loss Shot Just Created America’s Newest Trillion-Dollar Giant
3 Mins read
Nobody saw it happening this fast. A company once known mainly for diabetes treatments has just crashed through one of the biggest…
Chaos at Novo Nordisk: Shock Board Takeover Rocks the World’s Top Weight-Loss Drugmaker
2 Mins read
A Corporate Earthquake Hits Novo Nordisk In a move that has stunned investors and sent shockwaves through the pharmaceutical world, Novo Nordisk…



